Identifying prescribing cascades in Alzheimer's disease and related dementias: The calcium channel blocker‐diuretic prescribing cascade. Issue 8 (23rd March 2021)

• Record Type: Journal Article
• Authors: Singh, Sonal; Cocoros, Noelle M.; Haynes, Kevin; Nair, Vinit P.; Harkins, Thomas P.; Rochon, Paula A.; Platt, Richard; Dashevsky, Inna; Reynolds, Juliane; Mazor, Kathleen M.; Bloomstone, Sarah; Anzuoni, Kathryn; Crawford, Sybil L.; Gurwitz, Jerry H.
• Is Part Of: Pharmacoepidemiology and drug safety. Volume 30:Issue 8(2021)
• Page Start: 1066
• Page End: 1073
• Publication Date: 2021-03-23
• Subjects: Alzheimer's disease and related dementias -- medication safety -- older adults -- prescribing cascade; Pharmacoepidemiology -- Periodicals; Chemotherapy -- Periodicals; Epidemiology -- Periodicals; 615.705
• DOI: 10.1002/pds.5230
• Languages: English
• ISSNs: 1053-8569

Abstract

Abstract: Purpose: Prescribing cascades occur when a physician prescribes a new drug to address the side‐effect of another drug. Persons with Alzheimer's disease and related dementias (ADRD) are at increased risk for prescribing cascades. Our objective was to develop an approach to estimating the proportion of calcium channel blocker‐diuretic (CCB‐diuretic) prescribing cascades among persons with ADRD in two U.S. health plans. Methods: We identified patients aged ≥50 on January 1, 2017, dispensed a drug to treat ADRD in the 365‐days prior to/on cohort entry date. Patients had medical/pharmacy coverage for 1 year before and through cohort entry. We excluded individuals with an institutional stay encounter in the 45 days prior to cohort entry and censored patients based on: disenrollment from coverage, death, or end of data. We identified incident and prevalent CCB use in the 183‐days following cohort entry, and identified subsequent incident diuretic use among incident and prevalent CCB‐users within 365‐days from cohort entry. Results: There were 121 538 eligible patients. Approximately 62% were female, with a mean age of 79.5 (SD ±8.6). Overall 2.1% of the cohort experienced a prevalent CCB‐diuretic prescribing cascade with 1586 incident diuretic‐users among 36 462 prevalent CCB‐users (4.3%, 95% CI 4.1–4.6%]); and there were161 incident diuretic‐users among 3304 incident CCB‐users (4.9%, 95% CI 4.2–5.7%) (incident CCB‐diuretic cascade). Conclusions: We describe an approach to identify prescribing cascades in persons with ADRD, which can be used to assess the proportion of prescribing cascades in large cohorts. We determined the proportion of CCB‐diuretic prescribing cascades was low.